Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The current ratio is N/A as of Tuesday, October 6, 2026.
CURRENT RATIO
N/A
Market Cap
$83.96M
Current Ratio
7.03
TTM Avg
3.05
3Y Avg
3.90
5Y Avg
4.20
Market Cap
$84.70M
Current Ratio
1.98
TTM Avg
0.65
3Y Avg
1.44
5Y Avg
2.62
Market Cap
$84.75M
Current Ratio
7.99
TTM Avg
9.12
3Y Avg
12.06
5Y Avg
14.25
Market Cap
$79.46M
Current Ratio
1.00
TTM Avg
2.08
3Y Avg
2.75
5Y Avg
4.86
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Conexeu Sciences Inc. (CNXU) | $83.49M | N/A | N/A | N/A | N/A |
| Cognition Therapeutics, Inc. (CGTX)vs › | $83.96M | 7.03 | 3.05 | 3.90 | 4.20 |
| Humacyte, Inc. (HUMA)vs › | $84.00M | 6.21 | 3.04 | 4.62 | 7.16 |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $84.70M | 1.98 | 0.65 | 1.44 | 2.62 |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $84.75M | 7.99 | 9.12 | 12.06 | 14.25 |
| Citius Oncology, Inc. (CTOR)vs › | $81.22M | 0.73 | 0.45 | 0.43 | 0.43 |
| CareCloud, Inc. (CCLD)vs › | $86.69M | 1.02 | 1.16 | 1.22 | 1.27 |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $79.46M | 1.00 | 2.08 | 2.75 | 4.86 |
| Cardiff Oncology, Inc. (CRDF)vs › | $87.86M | 3.30 | 5.38 | 8.10 | 12.75 |
| ImmuCell Corporation (ICCC)vs › | $88.21M | 4.75 | 3.83 | 3.74 | 4.48 |
Current Ratio
N/A
Quick Ratio
N/A
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
